SavedAdd your journal

Journals / NanoEra / 2021 / Cilt: Volume 1 - Sayı: Issue 2

Development of Clay Nanoparticles in Pharmaceutical Industry

Shahriyar KARIMDOUST
Ekrem KALKAN
Yalcin Kemal BAYHAN
Yousef VASIGH
Beheshteh X BEHESHTEH GHARIBI
Journal
NanoEra
Pages
54–57
Publication Date
2021-12-30
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Scientists are conducting research to purify, modify and optimize bentonite minerals and obtain mineral drugs compatible with the body's biological system.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Nanotechnology has grown significantly in the medical field in recent years.
📊
Key Findings & Data:This new technology, with the synthesis and introduction of a new drug system, has made a huge difference in the discussion of treatment and health.
💡
Conclusion & Impact:Scientists are conducting research to purify, modify and optimize bentonite minerals and obtain mineral drugs compatible with the body's biological system.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Nanotechnology · Nano-clays · Pharmaceutical Industry

Abstract

Nanotechnology has grown significantly in the medical field in recent years. This new technology, with the synthesis and introduction of a new drug system, has made a huge difference in the discussion of treatment and health. The preparation and production of drugs based on natural and mineral compounds and the drug delivery system to specific organs of the body is an example of this technology in the field of pharmacy. Mineral drugs, unlike chemical drugs, have no negative effects on various organs of the body. Nano-clays -with their unique properties -are an example of mineral drugs that play a very important role in the pharmaceutical industry today. Bentonite is a clay mineral that is mainly composed of smectite minerals. Ionic substitution, ductility, high cation exchange are important properties of smectite minerals. Due to the weak bond between the layers in this group, it is easy to add different molecules andpolymers between their layers, and for this reason, the clay minerals of the smectite group are very important in the pharmaceutical industry. Scientists are conducting research to purify, modify and optimize bentonite minerals and obtain mineral drugs compatible with the body's biological system.

🔖

Cite This Article

KARIMDOUST, S., KALKAN, E., BAYHAN, Y. K., VASIGH, Y., GHARIBI, B. X. B. (2021). Development of Clay Nanoparticles in Pharmaceutical Industry. NanoEra, Cilt: Volume 1 - Sayı: Issue 2, 54–57. https://ajindex.com/articles/873767

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Carretero, M.I. Clay minerals and their beneficial effects upon human health. A review. Applied Clay Science2002, 21, 155–163, doi:10.1016/S0169-1317(01)00085-0
  2. Choy, J.; Choi, S.; Oh, J.; Park, T. Clay minerals and layered double hydroxides for novel biological applications. Applied Clay Science2007, 36, 122–132, doi:10.1016/j.clay.2006.07.007
  3. Kim, M.H.; Choi, G.; Elzatahry, A.; Vinu, A.; Choy, Y. Bin; Choy, J.-H. Review of Clay-drug Hybrid Materials for Biomedical Applications: Administration Routes. Clays and Clay Minerals2016, 64, 115–130, doi:10.1346/CCMN.2016.0640204
  4. Bergaya, F.; Lagaly, G. Chapter 1 General Introduction: Clays, Clay Minerals, and Clay Science 2006, 1–18
  5. Carretero, M.I.; Pozo, M. Clay and non-clay minerals in the pharmaceutical industry. Applied Clay Science2009, 46, 73–80, doi:10.1016/j.clay.2009.07.017
  6. López-Galindo, A.; Viseras, C.; Aguzzi, C.; Cerezo, P. Pharmaceutical and Cosmetic Uses of Fibrous Clays 2011, 299–324
  7. Carretero, M.I.; Gomes, C.S.F.; Tateo, F. Clays, Drugs, and Human Health 2013, 711–764
  8. Khurana, I.S.; Kaur, S.; Kaur, H.; Khurana, R.K. Multifaceted role of clay minerals in pharmaceuticals. Future Science OA2015, 1, FSO6, doi:10.4155/fso.15.6
  9. Massaro, M.; Colletti, C.; Lazzara, G.; Riela, S. The Use of Some Clay Minerals as Natural Resources for Drug Carrier Applications. Journal of Functional Biomaterials2018, 9, 58, doi:10.3390/jfb9040058
  10. Mousavi, S.M.; Hashemi, S.A.; Salahi, S.; Hosseini, M.; Amani,A.M.; Babapoor, A. Development of Clay Nanoparticles Toward Bio and Medical Applications. Current Topics in the Utilization of Clay in Industrial and Medical Applications2018, 167–191.11. Theng, K.G. The Chemistry of Clay-Organic Reactions. Adam HilgerLtd., Rank Precision Ind., 29 King Street, London, WC2E 8JH; 1974; ISBN 0852742118 9780852742112
  11. Nemecz, E. Clay Minerals. Budapest, Hungary: Akademiai Kiado; 1981
  12. Chung, H.-E.; Kim, I.-S.; Baek, M.; Yu, J.; Choi, S.-J. Long-term cytotoxicity potential of anionic nanoclays in human cells. Toxicology and Environmental Health Sciences2011, 3, 129–133, doi:10.1007/s13530-011-0088-z
  13. Sánchez, C.J.; Parras, J.; Carretero, M.I. The effect of maturation upon the mineralogical and physicochemicalproperties of illitic-smectitic clays for pelotherapy. Clay Minerals2002, 37, 457–463, doi:10.1180/0009855023730045
  14. Veniale, F.; Barberis, E.; Carcangiu, G.; Morandi, N.; Setti, M.; Tamanini, M.; Tessier, D. Formulation of muds fo